Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;71(4):245-254.
doi: 10.1111/pin.13081. Epub 2021 Mar 13.

Development of diagnostic antibodies against immunoglobulin heavy chain variable region for heavy chain amyloidosis (AH amyloidosis)

Mayuko Nakagawa  1   2 , Masahide Yazaki  1   2 , Fuyuki Kametani  3 , Nagaaki Katoh  4 , Tsuneaki Yoshinaga  1   4 , Keiichi Higuchi  1   5 , Yoshiki Sekijima  1   4
Affiliations

Development of diagnostic antibodies against immunoglobulin heavy chain variable region for heavy chain amyloidosis (AH amyloidosis)

Mayuko Nakagawa et al. Pathol Int. 2021 Apr.

Abstract

It is difficult to diagnose immunoglobulin heavy chain amyloidosis (AH amyloidosis) without proteomic analysis due to no useful diagnostic antibodies. The aim of this study was to develop diagnostic antibodies available to immunohistochemistry and immunoblotting. Two rabbit anti-heavy chain variable region antibodies were generated and evaluated in immunohistochemical studies performed on 11 AH amyloidosis patients and 64 patients with other systemic amyloidoses. Additionally, immunoblotting was performed using extracted amyloid protein from one patient and serum samples from two patients with AH amyloidosis. Immunohistochemical analysis generated a positive outcome in 10 of 11 AH amyloidosis patients (sensitivity 90.9%). While positive staining was also observed in 9 of 64 non-AH amyloidosis patients (specificity 85.9%), substitution of the blocking agent reversed the positive reactivity in 5 of 9 patients. Amyloid protein band was clearly detected via immunoblotting analysis, and protein bands with similar molecular weights of amyloid protein were observed in serum samples from patients with AH amyloidosis. The two antibodies may represent a powerful diagnostic tool for AH amyloidosis. In addition, our data revealed the existence of amyloidogenic variable region fragments in the serum of patients, suggesting their potential as diagnostic markers for AH amyloidosis.

Keywords: AH amyloidosis; diagnostic antibody; immunoglobulin heavy chain; immunohistochemistry; variable region.

PubMed Disclaimer

References

REFERENCES

    1. Benson MD, Buxbaum JN, Eisenberg DS et al. Amyloid nomenclature 2018: Recommendations by the International Society of Amyloidosis (ISA)nomenclature committee. Amyloid 2018; 25: 215-19.
    1. Kyle RA, Gertz MA. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45-59.
    1. Eulitz M, Weiss DT, Solomon A. Immunoglobulin heavy chain-associated amyloidosis. Proc Natl Acad Sci USA 1990; 87: 6542-46.
    1. Solomon A, Weiss DT, Murphy C. Primary amyloidosis associated with a novel heavy-chain fragment (AH amyloidosis). Am J Hematol 1994; 45: 171-76.
    1. Nasr SH, Lobritto SJ, Lauring BP, Arend LJ, D'Agati VD, Markowitz GS. A rare complication of monoclonal gammopathy. Am J Kidney Dis 2002; 40: 867-71.

LinkOut - more resources